These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 13575670)

  • 21. THE PRESENCE OF A VIRULENCE FACTOR IN M PROTEIN EXTRACTS OF GROUP A STREPTOCOCCI. I. THE ENHANCEMENT OF VIRULENCE OF HOMOLOGOUS STREPTOCOCCI BY THESE EXTRACTS.
    KRASNER RI; YOUNG G; HEITMANN R
    J Infect Dis; 1964 Dec; 114():401-11. PubMed ID: 14233130
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparation and antigenicity of M protein released from group A, type 1 streptococcal cell walls by phage-associated lysin.
    KANTOR FS; COLE RM
    J Exp Med; 1960 Jul; 112(1):77-96. PubMed ID: 13751222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.
    HIRSCH JG; CHURCH AB
    J Exp Med; 1960 Mar; 111(3):309-22. PubMed ID: 13714578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction.
    STOLLERMAN GH; EKSTEDT R
    J Exp Med; 1957 Sep; 106(3):345-56. PubMed ID: 13463246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE PROPERTIES OF T ANTIGENS EXTRACTED FROM GROUP A HEMOLYTIC STREPTOCOCCI.
    Lancefield RC; Dole VP
    J Exp Med; 1946 Oct; 84(5):449-71. PubMed ID: 19871581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phagocytosis of group A haemolytic streptococci by mouse macrophages. Comparison of preliminary infection of animals and degree of virulence of the strain (author's transl)].
    Wahl R; Wauquier I
    Z Immunitatsforsch Exp Klin Immunol; 1975 Feb; 148(4):273-84. PubMed ID: 126542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in the M antigen of group A streptococci: reassortment of type-specific markers and possible antigenic drift.
    Cleary P; Johnson D; Wannamaker L
    J Infect Dis; 1979 Nov; 140(5):747-57. PubMed ID: 93611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between the virulence of a culture and the presence of common (non-type-specific) antigens in strains of group A streptococcus of different types].
    Akimova VV; Shuratova SG; Bukhova VP; Kolesnikova VIu; Liampert IM
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):27-32. PubMed ID: 67728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEW METHOD OF PREPARING IMMUNIZING ANTIGENS FOR THE PRODUCTION OF ANTI-M SERA AGAINST CERTAIN SEROTYPES OF GROUP A STREPTOCOCCI.
    ASHWORTH H; HARRELL WK
    J Bacteriol; 1965 Jan; 89(1):141-5. PubMed ID: 14255654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced phagocytosis of group A streptococci M type 6 by oleic acid.
    Speert DP; Quie PG; Wannamaker LW
    J Infect Dis; 1981 Apr; 143(4):570-7. PubMed ID: 7017016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell surface antigens of Streptococcus equi.
    Erickson ED; Norcross NL
    Can J Comp Med; 1975 Apr; 39(2):110-5. PubMed ID: 804979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and immunobiological properties of R antigen and its relation to M protein of type 3 group A Streptococcus.
    Johnson RH; Beachey EH
    Infect Immun; 1979 Sep; 25(3):1051-9. PubMed ID: 91582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the pathogenicity of group A Streptococci. I. Its relation to surface phagocytosis.
    FOLEY MJ; SMITH MR; WOOD WB
    J Exp Med; 1959 Oct; 110(4):603-16. PubMed ID: 13823727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex surveillance of Streptococcus pyogenes. III. Immunological characteristics of streptococcal resistance in blood and new aspects of type nonspecific protection.
    Kahlich R
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):61-75. PubMed ID: 772126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unimpaired function of human phagocytes in the presence of phagocytosis-resistant group A streptococci.
    Manjula BN; Schmidt ML; Fischetti VA
    Infect Immun; 1985 Dec; 50(3):610-3. PubMed ID: 3905607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics.
    HALBERT SP; SWICK L; SONN C
    J Exp Med; 1955 May; 101(5):557-76. PubMed ID: 14367679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-protective antigens of group A streptococci types 3 and 31 and types 46 and 51.
    Harrell WK; Ashworth H; Davis RE
    Infect Immun; 1971 Jul; 4(1):79-84. PubMed ID: 5005288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of aggregated IgG in the presence of fresh serum: strong association with type 12 group A streptococci.
    Christensen P; Srámek J; Zätterström U
    Acta Pathol Microbiol Scand B; 1981 Apr; 89(2):87-91. PubMed ID: 7020343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. III. PRESENCE IN HUMAN SERA OF STREPTOCOCCAL ANTIBODY CROSS-REACTIVE WITH HEART TISSUE. ASSOCIATION WITH STREPTOCOCCAL INFECTION, RHEUMATIC FEVER, AND GLOMERULONEPHRITIS.
    KAPLAN MH; SVEC KH
    J Exp Med; 1964 Apr; 119(4):651-66. PubMed ID: 14151105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.